Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Immunophage Biotech
company
About
Immunophage Biotech is a Nanjing-based pharmaceutic company.
- 11 - 50
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $14.20M
- Industries
- Biotechnology,Pharmaceutical
- Founded date
- Jan 1, 2016
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Immunophage Biotech is a Chinese high-tech pharmaceutic company which was established in 2016. The R&D center of the company is located in the Pujiang High-Tech Park, Shanghai, China. They are developing first-in-class immune-regulating medicines against cancer, autoimmune diseases and neurodegenerative disorders.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$14.20M
Immunophage Biotech has raised a total of
$14.20M
in funding over 2 rounds. Their latest funding was raised on
Sep 28, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 28, 2021 | Series A | — | 1 | — | — | Detail |
| May 5, 2020 | Seed | $14.20M | 6 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
7
Immunophage Biotech is funded by 7 investors.
Jinfang Hongrui Investment Management
and Renjin Ziben
are the most recent investors.
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
